Innovation
2 patent families (1 granted) — focus: Chemistry & metallurgy; filing pace slowing. Cited 135 times.
| Year | Filings |
|---|---|
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
Social engagement
Social engagement: 4.3K social following, 5 posts in the last 12 months — below the industry typical range.
Investor mix
9 investors on record; lead investors include Daewoong, Hanall Biopharma.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 33% |
| Accelerator & incubator | 1 | 11% |
| Other / undisclosed | 5 | 56% |
Recent activity
23 Jun 2026
Event
Clinical Trials for Parkinson's disease webinar
22 Jun 2026
Event
extracellular vesicles webinar hosted by Spring Behrouz
